Healthcare & Lifesciences
Mergers & Acquisitions,
The Healthcare and Life Sciences industry is undergoing a dramatic ‘transformation’ and managing the business lifecycle has emerged as a pivotal focal point. Conjunction of the entire ecosystem, which includes pharma companies, insurance payers and providers, and other intercessors with the patient are at the centre of it.
The transaction value of M&A in US healthcare and life sciences industry alone was $165.8 billion in 2017. The global pharmaceutical excipients market is expected to grow at a CAGR of over 7% in the next 2 years.
This vast and extremely important industry, encompassing one of the largest spending accounts for most countries, will see unimaginable disruptions especially with the entry of Artificial Intelligence in the mainstream fold. This alone presents a USD 1.2 Trillion opportunity in its very first wave.
We are proud of having done very deep work in this critical industry, and are certain that our unparalleled edge on influential networks, deep understanding of industry dynamics, hands-on experiences will go a long way in helping you build a very strong, sustainable and an invaluable enterprise.